Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4 Purity >98.0% (HPLC) Lenvatinib Mesylate Intermediate Factory
Ruifu Chemical Supply Lenvatinib Mesylate Intermediates Ka Bohloeki bo Phahameng
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Lebitso la Lik'hemik'hale | Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate |
Litlhaloso tse tšoanang | Tšilafalo ea Lenvatinib 47;4-Chloro-7-Methoxyquinoline-6-Carboxylic Acid Methyl Ester;4-Chloro-7-Methoxy-6-Quinolinecarboxylic Acid Methyl Ester;Lenvaint-D |
Nomoro ea CAS | 205448-66-4 |
Nomoro ea KAtse | RF-PI1970 |
Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
Foromo ea limolek'hule | C12H10ClNO3 |
Boima ba Molek'hule | 251.67 |
Ntlha e belang | 377.4±37.0℃ |
Botenya | 1.320±0.06 g/cm3 |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo e Tiileng e Tletseng-Bosoeu ho isa ho Bosehla |
1 H NMR Spectrum | E Lumellanang le Sebopeho |
Mokhoa oa Bohloeki / Analysis | >98.0% (HPLC) |
Tahlehelo ka ho Omisa | <1.00% |
Litšila ka Kakaretso | <2.00% |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | Bohareng/Ho se hloeke ha Lenvatinib Mesylate (CAS: 857890-39-2) |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate (CAS: 205448-66-4) ke sebaka se bohareng sa Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib ke lithethefatsi tsa kankere ea qoqotho tse entsoeng ke Eisai Corporation ea Japane (Code: E7080), e leng ea inhibitor ea oral multi-receptor tyrosine kinase (RTK) 'me e ka thibela mosebetsi oa kinase oa vascular endothelial growth factor Receptors R1 (FLT1), VEG-FR2 (KDR), R3 (FLT4).Lenvatinib e ka boela ea thibela ho kenya letsoho ha li-RTK tse ling ho pathological angiogenesis, ho hōla ha hlahala, le tsoelo-pele ea kankere ntle le mesebetsi ea bona e tloaelehileng ea lisele tse kenyeletsang fibroblast growth factor (FGF) receptors FGFR1, 2, 3, le 4;platelet-derived growth factor receptor (PDGFR [alpha]), KIT, le RET.[Lipontšo]: Lenvatinib e loketse ho phekola bakuli ba mofetše oa qoqotho oa ho ipheta-pheta kapa mofuta oa metastasis, mofuta oa tsoelo-pele le mofuta o fapaneng oa iodine-refractory.